SCHEMBL8867974

SCHEMBL8867974

CSCC1=C(C(=O)O)N2C(=O)C(NC(=O)Cc3csc(N)n3)[C@H]2SC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.68
▸ LMNA P02545 2/20 0.68
▸ HSD17B10 Q99714 1/20 0.68
▸ L3MBTL1 Q9Y468 1/20 0.67
▸ NR1I2 O75469 4/20 0.53
▸ HTR2C P28335 1/20 0.53
▸ SLC22A6 Q4U2R8 3/20 0.51
▸ SLC22A8 Q8TCC7 3/20 0.51
▸ SLC22A11 Q9NSA0 3/20 0.51
▸ PPARG P37231 2/20 0.51
▸ PGR P06401 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ ALB P02768 1/20 0.51
▸ KMT2A Q03164 1/20 0.50
▸ DAO P14920 1/20 0.50
▸ SNCA P37840 1/20 0.50
▸ CYP2J2 P51589 1/20 0.50
▸ ABCC4 O15439 1/20 0.49
▸ POLB P06746 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8867984 1.00 TDP1 (0.68) TDP1LMNAHSD17B10L3MBTL1NR1I2
SCHEMBL11176964 0.90 TDP1 (0.65) TDP1LMNAHSD17B10L3MBTL1NR1I2
SCHEMBL11176958 0.90 TDP1 (0.65) TDP1LMNAHSD17B10L3MBTL1NR1I2
SCHEMBL11179539 0.88 TDP1 (0.67) TDP1LMNAHSD17B10L3MBTL1NR1I2
SCHEMBL11179548 0.88 TDP1 (0.67) TDP1LMNAHSD17B10L3MBTL1NR1I2
SCHEMBL23051121 0.88 TDP1 (0.66) TDP1LMNAHSD17B10L3MBTL1NR1I2
SCHEMBL11183181 0.87 TDP1 (0.68) TDP1LMNAHSD17B10L3MBTL1NR1I2
SCHEMBL11183173 0.87 TDP1 (0.68) TDP1LMNAHSD17B10L3MBTL1NR1I2
SCHEMBL11181090 0.87 TDP1 (0.67) TDP1LMNAHSD17B10L3MBTL1SLC22A6
SCHEMBL11181096 0.87 TDP1 (0.67) TDP1LMNAHSD17B10L3MBTL1SLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026695-A Gram negative-gram positive microbiocides, oral adminis tration FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-06-25 — — US claimed
EP-0029557-A2 7-Acylamino-3-substituted cephalosporanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-06-03 — — EP claimed
US-5594132-A ANTIBIOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-01-14 — — US disclosed
US-5026695-A Gram negative-gram positive microbiocides, oral adminis tration FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-06-25 — — US disclosed
US-4904652-A 7-acylamino-3-substituted cephalosporanic acid derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-02-27 — — US disclosed
US-4462999-A CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-07-31 — — US disclosed
US-4409215-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-10-11 — — US disclosed
EP-0029557-A2 7-Acylamino-3-substituted cephalosporanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-06-03 — — EP disclosed
Send feedback